Back to
VOLORIDGE INVESTMENT MANAGEMENT, LLC
CORT
Showing 4 of 23 quarters
Position history for
VOLORIDGE INVESTMENT MANAGEMENT, LLC's holdings in CORCEPT THERAPEUTICS INC
No. Voloridge Investment Management exited its CORT (Corcept Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 181,571 shares worth $20.7M. Voloridge Investment Management first reported CORT in Q3 2019 and held it in 21 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$28.8M
Total Shares Change
-622,171
Quarter-by-Quarter History